Thalomid (thalidomide) — Medica
Medulloblastoma
Initial criteria
- age < 18 years
- Patient has recurrent or progressive disease
- Medication is used as part of MEMMAT regimen (thalidomide, celecoxib, fenofibrate, oral etoposide, cyclophosphamide, bevacizumab, intraventricular etoposide)
Approval duration
1 year